These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 14601152)

  • 41. Relationship between utility values and willingness to pay in patients undergoing orthognathic treatment.
    Cunningham SJ; Hunt NP
    Community Dent Health; 2000 Jun; 17(2):92-6. PubMed ID: 11349993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Willingness to pay for health care services in common cold, retinal detachment, and myocardiac infarction: an internet survey in Japan.
    Yasunaga H; Ide H; Imamura T; Ohe K
    BMC Health Serv Res; 2006 Feb; 6():12. PubMed ID: 16504017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The economic value of informal care: a study of informal caregivers' and patients' willingness to pay and willingness to accept for informal care.
    van den Berg B; Bleichrodt H; Eeckhoudt L
    Health Econ; 2005 Apr; 14(4):363-76. PubMed ID: 15744739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Willingness to pay for cataract surgery in two regions of Tanzania.
    Lewallen S; Geneau R; Mahande M; Msangi J; Nyaupumbwe S; Kitumba R
    Br J Ophthalmol; 2006 Jan; 90(1):11-3. PubMed ID: 16361657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does willingness to pay per quality-adjusted life year bring us closer to a useful decision rule for cost-effectiveness analysis?
    Polsky D
    Med Decis Making; 2005; 25(6):605-6. PubMed ID: 16282209
    [No Abstract]   [Full Text] [Related]  

  • 46. Discounting for health effects in cost-benefit and cost-effectiveness analysis.
    Gravelle H; Smith D
    Health Econ; 2001 Oct; 10(7):587-99. PubMed ID: 11747043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation.
    Bobinac A; van Exel NJ; Rutten FF; Brouwer WB
    J Health Econ; 2012 Jan; 31(1):158-68. PubMed ID: 22018622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics.
    Bridges JF
    Appl Health Econ Health Policy; 2003; 2(4):213-24. PubMed ID: 15119540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measuring willingness-to-pay for risk reduction: an application of conjoint analysis.
    Telser H; Zweifel P
    Health Econ; 2002 Mar; 11(2):129-39. PubMed ID: 11921311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of two methods for eliciting contingent valuations of colorectal cancer screening.
    Whynes DK; Frew E; Wolstenholme JL
    J Health Econ; 2003 Jul; 22(4):555-74. PubMed ID: 12842315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating the monetary value of health care: lessons from environmental economics.
    Hanley N; Ryan M; Wright R
    Health Econ; 2003 Jan; 12(1):3-16. PubMed ID: 12483757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On aggregating QALYs: a comment on Dolan.
    Johannesson M
    J Health Econ; 1999 Jun; 18(3):381-6. PubMed ID: 10537901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A welfare economic approach to measure outcomes in stuttering: comparing willingness to pay and quality adjusted life years.
    Franic DM; Bothe AK; Bramlett RE
    J Fluency Disord; 2012 Dec; 37(4):300-13. PubMed ID: 23218213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The willingness to pay for health changes, the human-capital approach and the external costs.
    Johannesson M
    Health Policy; 1996 Jun; 36(3):231-44. PubMed ID: 10158268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group.
    Weinstein MC; Siegel JE; Garber AM; Lipscomb J; Luce BR; Manning WG; Torrance GW
    Health Econ; 1997; 6(5):505-10. PubMed ID: 9353651
    [No Abstract]   [Full Text] [Related]  

  • 56. Willingness-to-pay for community-based insurance in Burkina Faso.
    Dong H; Kouyate B; Cairns J; Mugisha F; Sauerborn R
    Health Econ; 2003 Oct; 12(10):849-62. PubMed ID: 14508869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma.
    Blumenschein K; Johannesson M
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):189-94. PubMed ID: 9494453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Constant and decreasing timing aversion for saving lives.
    Cairns J; van der Pol M
    Soc Sci Med; 1997 Dec; 45(11):1653-9. PubMed ID: 9428085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Willingness to pay for depression treatment in primary care.
    Unützer J; Katon WJ; Russo J; Simon G; von Korff M; Lin E; Walker E; Ludman E; Bush T
    Psychiatr Serv; 2003 Mar; 54(3):340-5. PubMed ID: 12610241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conjoint analysis. The cost variable: an Achilles' heel?
    Slothuus Skjoldborg U; Gyrd-Hansen D
    Health Econ; 2003 Jun; 12(6):479-91. PubMed ID: 12759917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.